The 10th Conference on Cancer therapy with Antibodies and Immunoconjugates

Last Modified: April 14, 2004

Share article

Conference Dates: October 21-23, 2004
Conference Location: Princeton, NJ

Sponsoring Group: Imedex, Inc.

Conference Web Page URL:

Registration Information: Online at; Tel: +1 770 751 7332; Fax: +1 770 751 7334; Email:

Continuing Education: Yes

ASCO: Combo Antibody Therapy Effective for Melanoma

May 20, 2013 - Concurrent use of two immune checkpoint antibodies -- ipilimumab and nivolumab -- may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in advance of the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More